socalTECH

SEPTEMBER 23, 2011

Prolacta is venture backed by Alta Partners, Arcturus Capital, DFJ Frontier, DFJ Mercury Venture Partners, Draper Associates, Draper Richards, Funk Ventures, Gideon Hixon Fund, and Philip Capital. READ MORE>>.

Arcturus 166

Arcturus Draper Monrovia Capital 166

socalTECH

JANUARY 15, 2010

ONDAX is backed by Arcturus Capital, Prospector Equity Capital, and others. Moser is a native of Switzerland, and will remain as Chief Technology Officer at the firm. Heyler was most recently at Newport Corporation.

Arcturus 124

Arcturus Chief Technology Officer Monrovia Equity 124

socalTECH

JUNE 19, 2009

Dr. Schuh was previously CEO and Director of AviaraDx, and also served at Arcturus Bioscience and Sequenom. Tags: sorrento therapeutics biotech venture capital lifescience aviaradx. The firm is headed by Antonius Schuh, who serves as founding chairman and CEO; the firm's CFO is Steve Zaniboni.

Arcturus 100

Arcturus San Diego Venture Capital Equity 100

socalTECH

SEPTEMBER 3, 2010

The firm is venture backed by Anthem Ventures, Arcturus Capital, Capital One, Capricorn Management, and GRP Partners. Painter is best known for being the founder and CEO of CarsDirect.com, but is also heavily involved in local startups such as SharesPost, and other firms through his BrightHouse business incubator.

Truecar 154

Truecar Pricing Tool Arcturus 154

socalTECH

SEPTEMBER 10, 2008

The firm said it has scored Series A funding from Zag, Anthem Venture Partners, Global Retail Partners, Capricorn, Capital One Auto Finance, ARcturus Capital, Scott Painter, and co-founder Tom Taira. According to TrueCar, it will provide information about new car pricing, using the actual price people have paid for cars.

Zag 133

Zag Truecar CarsDirect Arcturus 133

socalTECH

APRIL 27, 2009

TrueCar is venture backed by Zag, Anthem Venture Partners, Global Retail Partners, Capricorn, Capital One Auto Finance, and Arcturus Capital. The new service is free, and is based on automotive transactions within the last four weeks. READ MORE>>.

Truecar 100

Truecar Pricing Zag Sites 100

socalTECH

DECEMBER 1, 2010

Prolacta is venture backed by Alta Partners, DFJ Frontier, Arcturus Capital, DFJ Mercury, Funk Ventures, Phillip Capital, Gideon Hixon Fund, and Draper Associates L.P. READ MORE>>.

Arcturus 124

Arcturus Draper Monrovia Screening 124

socalTECH

JULY 7, 2009

Zag has previously received venture capital from such firms as Anthem Ventures, GRP Partners, the Tech Coast Angels, Capricorn Management, Capital One, and Arcturus Capital. The firm did not say what drove the growth, and did not provide any financial details on its sales or profitability. READ MORE>>.

Zag 100

Zag Sales CarsDirect Tech Coast Angels 100

socalTECH

JANUARY 22, 2009

Zag has previously received funding from Anthem Ventures, Arcturus Capital, Capital One, Capricorn Management, GRP Partners, and the Tech Coast Angels. Tags: automobile venture auto capital funding. The firm recently spun out True Car, an automotive pricing information site. READ MORE>>.

Zag 100

Zag Funding Tech Coast Angels Arcturus 100

socalTECH

JANUARY 22, 2009

Zag is venture backed by Anthem Ventures, Arcturus Capital, Capital One, Capricorn Management, GRP Partners, and the Tech Coast Angels, along with USAA. Tags: automobile auto venture funding capital. The firm recently spun out True Car, an automotive pricing information site. READ MORE>>.

Zag 100

Zag Tech Coast Angels Arcturus GRP Partners 100

socalTECH

OCTOBER 24, 2008

The round was led by Rincon Venture Partners, and also included Arcturus Capital and Momentum Venture Management. According to Momentum Venture Management, which announced the deal, the round has not yet closed and is adding a "small amount" of additional capital before closing the round. in a Series A funding round.

Arcturus 100

Arcturus Long Beach Resource Capital 100

socalTECH

OCTOBER 6, 2008

Zag has now signed up 14 AAA motor clubs, and also provides its technology to Capital One Auto Finance, Overstock.com, and other sites. Zag is headed by former CarsDirect CEO Scott Painter, and is venture backed by Anthem Venture Partners, Capital One Auto Finance, GRP Partners, Arcturus Capital, Callaway Cars and the Skoll Fund.

Zag 100

Zag CarsDirect Arcturus GRP Partners 100

socalTECH

APRIL 1, 2009

Zag is venture backed by Anthem Venture Partners, USAA, GRP Partners, Arcturus Capital, Callaway Cars and the Skoll Fund. Zag's technology differs from other similar programs in that it offers fully detailed pricing on exact options, rather than just feeding leads into a dealership's fleet or online department. READ MORE>>.

Zag 100

Zag Services Arcturus GRP Partners 100

socalTECH

OCTOBER 14, 2008

The firm is backed by Anthem Venture Partners, Capital One Auto Finance, GRP Partners, Arcturus Capital, Callaway Cars and the Skoll Fund. Zag develops software used for configuring and pricing new and used automobiles, which it provides on a white-label basis to affinity buying programs. READ MORE>>

Zag 100

Zag Arcturus GRP Partners Anthem 100

socalTECH

OCTOBER 21, 2013

San Diego-based Arcturus Therapeutics , a developer of RNAi technology, said it has raised $5M in a Series A funding round. According to Arcturus, the funding came from multiple private capital,, high net worth investors from Canada, Japan, and the United States. Names of those capital sources were not announced.

Arcturus 153

Arcturus San Diego .Net Venture Capital 153

socalTECH

JUNE 3, 2013

San Diego-based Arcturus Therapeutics , which is developing RNAi therapeutics to treat disease, said this morning that it has raised $1.3M Arcturus Therapeutics is headed by Joseph E. Arcturus Therapeutics is headed by Joseph E. arcturus therapeutics venture capital rnai lifescience biotech' and Canada.

Arcturus 138

Arcturus San Diego .Net Venture Capital 138

Xconomy

APRIL 17, 2020

The public markets are moving erratically, but Alnylam Pharmaceuticals showed this week that selling equity isn’t the only way for biotech companies to raise cash. Late last year Alnylam (NASDAQ: ALNY ) began exploring potential royalty deals for inclisiran, a drug that uses RNA interference to lower cholesterol.

Equity 84

Equity Activity Marketing Company 84

Xconomy

MARCH 2, 2018

Biotech startups rolled in cash this week. By our count, investors put more than $800 million into life-sciences startups in four days. The money came from a wide range of backers, not just traditional biotech venture firms. It’s early yet in 2018, but the current count could put life-sciences companies on pace to bust past last year’s $17.6

Funding 52

Funding Report Startup Venture Capital 52